Gil, T.

patient treatment cancer m-cavi cisplatin oncology phase response group study chemotherapy survival oncology information downloaded toxicity gemcitabine m-cavi arm trial society american society bajorin bajorin risk groups gc arm death reason grade 3 grade firmed /carboplatin firmed uncon firmed medische bibliotheek urothelial erasmus mc methotrexate factor disease cisplatin-based chemotherapy bladder month result oncol bajorin risk factors bladder cancer information 0.0 randomized santi carboplatin cisplatin therapy analysis author status fit patients urothelial cancer carcinoma american fi ltration rate response rate eli lilly progression joaquim bellmunt therapy combination cell carcinoma regimen function number iwona skoneczna erasmu cisplatin-based table bellmunt difference treatment arms creatinine clearance 60 ml /min bibliotheek americanfrom downloaded medische gemcitabine /carboplatin m-cavi